Search

Search Constraints

You searched for: Author/Creator Uegaki, Masayuki

Search Results

1. Amino‐terminal enhancer of split gene AES encodes a tumor and metastasis suppressor of prostate cancer. Issue 4 (12th April 2017)

2. Decreased expression of lysophosphatidylcholine (16:0/OH) in high resolution imaging mass spectrometry independently predicts biochemical recurrence after surgical treatment for prostate cancer. Issue 16 (1st September 2015)

3. Downregulation of RalGTPase-activating protein promotes invasion of prostatic epithelial cells and progression from intraepithelial neoplasia to cancer during prostate carcinogenesis. (6th May 2019)

4. Immune‐related adverse events in urothelial cancer patients: Adjustment for immortal time bias. Issue 11 (2nd September 2022)

5. Impact of the objective response to and number of cycles of platinum‐based first‐line chemotherapy for metastatic urothelial carcinoma on overall survival of patients treated with pembrolizumab. (20th September 2021)

6. Pembrolizumab for treating advanced urothelial carcinoma in patients with impaired performance status: Analysis of a Japanese nationwide cohort. (1st May 2021)

8. The efficacy of sequential therapy with docetaxel and cabazitaxel for castration‐resistant prostate cancer: A retrospective multi‐institutional study in Japan. (14th November 2022)

9. Up‐regulation of miR‐582‐5p regulates cellular proliferation of prostate cancer cells under androgen‐deprived conditions. Issue 16 (29th August 2014)

10. Up‐regulation of secretory leukocyte protease inhibitor in human samples might have a potential role of predicting prostate cancer recurrence and progression after surgery and hormonal therapy. (13th August 2022)